Delphine Lebrun

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Validation of the Fautrel classification criteria for adult-onset Still’s disease

Delphine Lebrun, S. Mestrallet, Monique Dehoux et al. · Seminars in Arthritis and Rheumatism · 2017 · 72 citations · Full text

Aging, Disease Progression, Geriatrics +7

Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort

Delphine Lebrun, Maxime Hentzien, Lise Cuzin et al. · AIDS · 2017 · 57 citations

Severe acute hepatitis E in an HIV infected patient: Successful treatment with ribavirin

A. Robbins, D Lambert, Florent Ehrhard et al. · Journal of Clinical Virology · 2014 · 30 citations

Successful Treatment, Viral Hepatitis, Antiviral Therapy +6

Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.

Agathe Bonnaire, Véronique Vernet-Garnier, Delphine Lebrun et al. · Diagnostic Microbiology and Infectious Disease · 2020 · 21 citations · Full text

Antimicrobial Susceptibility, Antibiotics, Orthopaedic Surgery +11